P1.25. Complete Pathologic Response (pCR) as a Surrogate Endpoint in Neoadjuvant Immunotherapy Clinical Trials for NSCLC: A Meta-analysis - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Jacobi Hines
Meta Tag
Speaker Jacobi Hines
Topic Early-Stage NSCLC: Changing Paradigms & Outcomes
Keywords
complete pathologic response
pCR
neoadjuvant immunotherapy
clinical trials
non-small cell lung cancer
NSCLC
meta-analysis
event-free survival
hazard ratios
odds ratios
Powered By